Literature DB >> 26248258

Challenge accepted: Human challenge trials for dengue.

Wudan Yan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26248258     DOI： 10.1038/nm0815-828

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Efficacy of a tetravalent dengue vaccine in children in Latin America.

Authors:  Luis Villar; Gustavo Horacio Dayan; José Luis Arredondo-García; Doris Maribel Rivera; Rivaldo Cunha; Carmen Deseda; Humberto Reynales; Maria Selma Costa; Javier Osvaldo Morales-Ramírez; Gabriel Carrasquilla; Luis Carlos Rey; Reynaldo Dietze; Kleber Luz; Enrique Rivas; Maria Consuelo Miranda Montoya; Margarita Cortés Supelano; Betzana Zambrano; Edith Langevin; Mark Boaz; Nadia Tornieporth; Melanie Saville; Fernando Noriega
Journal:  N Engl J Med       Date:  2014-11-03       Impact factor: 91.245

2.  Research on dengue during World War II.

Authors:  A B SABIN
Journal:  Am J Trop Med Hyg       Date:  1952-01       Impact factor: 2.345

3.  A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness.

Authors:  V J Gunther; R Putnak; K H Eckels; M P Mammen; J M Scherer; A Lyons; M B Sztein; W Sun
Journal:  Vaccine       Date:  2011-04-13       Impact factor: 3.641

4.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

5.  Dengue virus inhibits the production of type I interferon in primary human dendritic cells.

Authors:  Juan R Rodriguez-Madoz; Dabeiba Bernal-Rubio; Dorota Kaminski; Kelley Boyd; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

6.  Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.

Authors:  Wellington Sun; Kenneth H Eckels; J Robert Putnak; Arthur G Lyons; Stephen J Thomas; David W Vaughn; Robert V Gibbons; Stefan Fernandez; Vicky J Gunther; Mammen P Mammen; John D Statler; Bruce L Innis
Journal:  J Infect Dis       Date:  2012-12-05       Impact factor: 5.226

7.  Evaluation of dengue virus strains for human challenge studies.

Authors:  M P Mammen; A Lyons; B L Innis; W Sun; D McKinney; R C Y Chung; K H Eckels; R Putnak; N Kanesa-thasan; J M Scherer; J Statler; L V Asher; S J Thomas; D W Vaughn
Journal:  Vaccine       Date:  2014-01-24       Impact factor: 3.641

8.  Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum.

Authors:  J D Chulay; I Schneider; T M Cosgriff; S L Hoffman; W R Ballou; I A Quakyi; R Carter; J H Trosper; W T Hockmeyer
Journal:  Am J Trop Med Hyg       Date:  1986-01       Impact factor: 2.345

9.  CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice.

Authors:  Raphaël M Zellweger; William E Eddy; William W Tang; Robyn Miller; Sujan Shresta
Journal:  J Immunol       Date:  2014-09-12       Impact factor: 5.422

10.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.

Authors:  Maria Rosario Capeding; Ngoc Huu Tran; Sri Rezeki S Hadinegoro; Hussain Imam H J Muhammad Ismail; Tawee Chotpitayasunondh; Mary Noreen Chua; Chan Quang Luong; Kusnandi Rusmil; Dewa Nyoman Wirawan; Revathy Nallusamy; Punnee Pitisuttithum; Usa Thisyakorn; In-Kyu Yoon; Diane van der Vliet; Edith Langevin; Thelma Laot; Yanee Hutagalung; Carina Frago; Mark Boaz; T Anh Wartel; Nadia G Tornieporth; Melanie Saville; Alain Bouckenooghe
Journal:  Lancet       Date:  2014-07-10       Impact factor: 79.321
  10 in total
  1 in total

1.  An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.

Authors:  Chad K Porter; Mark S Riddle; Ashley N Alcala; David A Sack; Clayton Harro; Subhra Chakraborty; Ramiro L Gutierrez; Stephen J Savarino; Michael Darsley; Robin McKenzie; Barbara DeNearing; Hans Steinsland; David R Tribble; A Louis Bourgeois
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.